Sevoflurane-remifentanyl versus propofol-remifentanyl in surgery exceeding 4 hours

Completed

• Conditions: Prolonged surgery; Surgery

• Registration Number: ISRCTN25537214
• Lead Sponsor: Addenbrooke's Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-11-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients undergoing surgery over 4 hours.

Exclusion Criteria

1. Allergy to sevoflurane or remifentanyl
2. Patient refusal
3. Morbidly obese
4. American Society of Anesthesiologists (ASA) 3 or higher

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Haemodynamic stability

Secondary Outcome Measures

Name	Time	Method
1. Nausea<br>2. Vomiting<br>3. Wake up time